scispace - formally typeset
J

Jeffrey B. Boord

Researcher at Vanderbilt University Medical Center

Publications -  9
Citations -  1300

Jeffrey B. Boord is an academic researcher from Vanderbilt University Medical Center. The author has contributed to research in topics: Insulin resistance & Metabolic syndrome. The author has an hindex of 7, co-authored 9 publications receiving 1243 citations.

Papers
More filters
Journal ArticleDOI

Combined Adipocyte-Macrophage Fatty Acid–Binding Protein Deficiency Improves Metabolism, Atherosclerosis, and Survival in Apolipoprotein E–Deficient Mice

TL;DR: Combined aP2 and mal1 deficiency improved glucose and lipid metabolism, reduced atherosclerosis, and improved survival in apoE−/− mice, making these proteins important therapeutic targets for the prevention of the cardiovascular consequences of the metabolic syndrome.
Journal ArticleDOI

Adipocyte Fatty Acid–Binding Protein, aP2, Alters Late Atherosclerotic Lesion Formation in Severe Hypercholesterolemia

TL;DR: An important role for aP2 expression in the advanced stages of atherosclerotic lesion formation is demonstrated, demonstrating an important physiological link between different features of the metabolic syndrome and is a potential target for therapy of Atherosclerosis.
Journal ArticleDOI

Cytoplasmic fatty acid-binding proteins: emerging roles in metabolism and atherosclerosis.

TL;DR: Interestingly, expression of aP2 by the macrophage promotes atherogenesis, thus providing a link between insulin resistance, intracellular fatty acid disposition, and foam cell formation, and the FABPs are promising targets for the treatment of dyslipidemia, insulin resistance and atherosclerosis in humans.